Decoy Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 4.03 K | $29.00 K | 100.00% | 0.76% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 256 | $1.84 K | -74.93% | 0.05% |
| UBS GROUP AG | 08/13/2026 | 25 | $180 | -95.42% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 2 | $14 | 100.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ADVISORY SERVICES NETWORK, LLC | 08/12/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Decoy Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 6 institutional investors and hedge funds held shares of Decoy Therapeutics Inc.. The most heavily invested institutionals were:
VANGUARD CAPITAL MANAGEMENT LLC: 4,034
Tower Research Capital LLC (TRC): 256
UBS Group AG: 25
Caitong International Asset Management Co., Ltd: 2
Advisory Services Network, LLC: 0
MORGAN STANLEY: 0
0.81% of Decoy Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.32 K shares in the last 24 months. This purchase volume represents approximately $37.17 K in transactions.